Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
<p>Abstract</p> <p>Background</p> <p>Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumour necrosis factor cytokine family that induces apoptosis upon binding to its death domain containing receptors, TRAIL receptor 1 (DR4) and TRAIL...
Main Authors: | Hussain Azhar R, Al-Dayel Fouad, Alhomoud Samar, Ashari Luai H, Abduljabbar Alaa, Al-Sanea Nasser, George Thara, Qadri Zeeshan, Abubaker Jehad, Prabhakaran Sarita E, Bavi Prashant, Uddin Shahab, Al-Kuraya Khawla S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/203 |
Similar Items
-
KRAS and TP53 mutations in colorectal carcinoma
by: Al-Kuraya Khawla
Published: (2009-01-01) -
Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma
by: Shahab Uddin, et al.
Published: (2012-07-01) -
Radioactive iodine refractoriness in Middle Eastern differentiated thyroid cancer: clinical outcome and risk factor analysis
by: Sandeep Kumar Parvathareddy, et al.
Published: (2024-05-01) -
Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity
by: Rong Bu, et al.
Published: (2023-11-01) -
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
by: Marina Salmón, et al.
Published: (2023-04-01)